255 related articles for article (PubMed ID: 8119950)
1. Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling.
Tanti JF; Grémeaux T; van Obberghen E; Le Marchand-Brustel Y
J Biol Chem; 1994 Feb; 269(8):6051-7. PubMed ID: 8119950
[TBL] [Abstract][Full Text] [Related]
2. Okadaic acid exerts a full insulin-like effect on glucose transport and glucose transporter 4 translocation in human adipocytes. Evidence for a phosphatidylinositol 3-kinase-independent pathway.
Rondinone CM; Smith U
J Biol Chem; 1996 Jul; 271(30):18148-53. PubMed ID: 8663361
[TBL] [Abstract][Full Text] [Related]
3. Insulin regulation of membrane-associated insulin receptor substrate 1.
Heller-Harrison RA; Morin M; Czech MP
J Biol Chem; 1995 Oct; 270(41):24442-50. PubMed ID: 7592659
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor inhibits insulin stimulation of insulin receptor substrate-1-associated phosphatidylinositol 3-kinase in 3T3-L1 adipocytes without affecting glucose transport.
Staubs PA; Nelson JG; Reichart DR; Olefsky JM
J Biol Chem; 1998 Sep; 273(39):25139-47. PubMed ID: 9737973
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of okadaic acid on insulin-stimulated glucose and amino acid uptake and phosphatidylinositol 3-kinase activity.
Jullien D; Tanti JF; Heydrick SJ; Gautier N; Grémeaux T; Van Obberghen E; Le Marchand-Brustel Y
J Biol Chem; 1993 Jul; 268(20):15246-51. PubMed ID: 8392070
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action.
Mothe I; Van Obberghen E
J Biol Chem; 1996 May; 271(19):11222-7. PubMed ID: 8626671
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1.
Kanety H; Feinstein R; Papa MZ; Hemi R; Karasik A
J Biol Chem; 1995 Oct; 270(40):23780-4. PubMed ID: 7559552
[TBL] [Abstract][Full Text] [Related]
8. Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation.
Pederson TM; Kramer DL; Rondinone CM
Diabetes; 2001 Jan; 50(1):24-31. PubMed ID: 11147790
[TBL] [Abstract][Full Text] [Related]
9. Hyperosmotic stress inhibits insulin receptor substrate-1 function by distinct mechanisms in 3T3-L1 adipocytes.
Gual P; Gonzalez T; Grémeaux T; Barres R; Le Marchand-Brustel Y; Tanti JF
J Biol Chem; 2003 Jul; 278(29):26550-7. PubMed ID: 12730242
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory effect of staurosporine on insulin action is prevented by okadaic acid. Evidence for an important role of serine/threonine phosphorylation in eliciting insulin-like effects.
Rondinone CM; Zarnowski MJ; Londos C; Smith UP
Biochim Biophys Acta; 1996 Nov; 1314(1-2):49-56. PubMed ID: 8972717
[TBL] [Abstract][Full Text] [Related]
11. Cross-talk between the platelet-derived growth factor and the insulin signaling pathways in 3T3-L1 adipocytes.
Ricort JM; Tanti JF; Van Obberghen E; Le Marchand-Brustel Y
J Biol Chem; 1997 Aug; 272(32):19814-8. PubMed ID: 9242642
[TBL] [Abstract][Full Text] [Related]
12. Okadaic acid inhibits insulin-induced glucose transport in fetal brown adipocytes in an Akt-independent and protein kinase C zeta-dependent manner.
Valverde AM; Lorenzo M; Navarro P; Mur C; Benito M
FEBS Lett; 2000 Apr; 472(1):153-8. PubMed ID: 10781824
[TBL] [Abstract][Full Text] [Related]
13. Mutation of tyrosine 960 within the insulin receptor juxtamembrane domain impairs glucose transport but does not inhibit ligand-mediated phosphorylation of insulin receptor substrate-2 in 3T3-L1 adipocytes.
Chaika OV; Chaika N; Volle DJ; Hayashi H; Ebina Y; Wang LM; Pierce JH; Lewis RE
J Biol Chem; 1999 Apr; 274(17):12075-80. PubMed ID: 10207032
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes.
He J; Usui I; Ishizuka K; Kanatani Y; Hiratani K; Iwata M; Bukhari A; Haruta T; Sasaoka T; Kobayashi M
Mol Endocrinol; 2006 Jan; 20(1):114-24. PubMed ID: 16150868
[TBL] [Abstract][Full Text] [Related]
15. Regulation of insulin receptor, insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-F442A adipocytes. Effects of differentiation, insulin, and dexamethasone.
Saad MJ; Folli F; Araki E; Hashimoto N; Csermely P; Kahn CR
Mol Endocrinol; 1994 May; 8(5):545-57. PubMed ID: 7520127
[TBL] [Abstract][Full Text] [Related]
16. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes.
Ishibashi KI; Imamura T; Sharma PM; Huang J; Ugi S; Olefsky JM
J Clin Invest; 2001 May; 107(9):1193-202. PubMed ID: 11342583
[TBL] [Abstract][Full Text] [Related]
17. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes.
Yaworsky K; Somwar R; Ramlal T; Tritschler HJ; Klip A
Diabetologia; 2000 Mar; 43(3):294-303. PubMed ID: 10768090
[TBL] [Abstract][Full Text] [Related]
18. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
[TBL] [Abstract][Full Text] [Related]
19. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
20. Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes.
Egawa K; Nakashima N; Sharma PM; Maegawa H; Nagai Y; Kashiwagi A; Kikkawa R; Olefsky JM
Endocrinology; 2000 Jun; 141(6):1930-5. PubMed ID: 10830273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
